Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity

JM Ntambi, M Miyazaki, JP Stoehr… - Proceedings of the …, 2002 - National Acad Sciences
JM Ntambi, M Miyazaki, JP Stoehr, H Lan, CM Kendziorski, BS Yandell, Y Song, P Cohen…
Proceedings of the National Academy of Sciences, 2002National Acad Sciences
Stearoyl–CoA desaturase (SCD) is a central lipogenic enzyme catalyzing the synthesis of
monounsaturated fatty acids, mainly oleate (C18: 1) and palmitoleate (C16: 1), which are
components of membrane phospholipids, triglycerides, wax esters, and cholesterol esters.
Several SCD isoforms (SCD1-3) exist in the mouse. Here we show that mice with a targeted
disruption of the SCD1 isoform have reduced body adiposity, increased insulin sensitivity,
and are resistant to diet-induced weight gain. The protection from obesity involves increased …
Stearoyl–CoA desaturase (SCD) is a central lipogenic enzyme catalyzing the synthesis of monounsaturated fatty acids, mainly oleate (C18:1) and palmitoleate (C16:1), which are components of membrane phospholipids, triglycerides, wax esters, and cholesterol esters. Several SCD isoforms (SCD1-3) exist in the mouse. Here we show that mice with a targeted disruption of the SCD1 isoform have reduced body adiposity, increased insulin sensitivity, and are resistant to diet-induced weight gain. The protection from obesity involves increased energy expenditure and increased oxygen consumption. Compared with the wild-type mice the SCD1−/− mice have increased levels of plasma ketone bodies but reduced levels of plasma insulin and leptin. In the SCD1−/− mice, the expression of several genes of lipid oxidation are up-regulated, whereas lipid synthesis genes are down-regulated. These observations suggest that a consequence of SCD1 deficiency is an activation of lipid oxidation in addition to reduced triglyceride synthesis and storage.
National Acad Sciences